HPV Vaccine ‘Protects Males from Cancers’ – Global Report [Video]

Latest global HPV vaccine study

• The study included an estimated 1.7 million volunteers who were vaccinated against HPV since 2010.

• Volunteers were aged between nine and 39. There were equal numbers of unvaccinated volunteers. In total, about 44% of those who took part were male.

• Vaccinated males had lower rates of head and neck cancers in particular. Previously, it was believed smoking was the biggest single cause of head and neck cancers.

• The study showed that per 100,000 vaccinated patients, 3.4 cases (head) and 2.8 cases (neck) of cancers, compared with 7.5 (head) and 6.3 (neck) per 100,000 of unvaccinated patients.

Boys and men can benefit from human papillomavirus (HPV) vaccination, which can cut the risk of a range of cancers, a new study shows.

The study of around 3.4 million people is one of the first long-term analyses of the vaccine’s efficacy on preventing HPV-related cancers of the head and neck, anal areas, penis, vulva, vagina and cervix, Reuters reports. 

Previous HPV …